Evaluation of Effect of Renal Impairment on the PK of Tenofovir Exalidex

• Status: Completed
• Trial end date: 2018-02-20
• Target enrollment: 0
• Participant gender: All

Summary

This is a Phase 1 study to investigate the effects of Renal Impairment on the pharmacokinetics of Tenofovir exalidex

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: ContraVir Pharmaceuticals, Inc.
• Treatments: Tenofovir

Criteria

Inclusion Criteria:

• Age: 18 years of age and over

• Capable of giving written informed consent

• Capable of completing study requirements

Exclusion Criteria:

• Positive result for HIV, HBV, or HCV

• History or medical condition which could impact patient safety

• Current or past abuse of alcohol or drugs

• Participation in another clinical trial within the past 30 days